Gisele Dion - Net Worth and Insider Trading

Gisele Dion Net Worth

The estimated net worth of Gisele Dion is at least $32,350 dollars as of 2024-12-13. Gisele Dion is the Director of Cytek Biosciences Inc and owns about 5,000 shares of Cytek Biosciences Inc (CTKB) stock worth over $32,350. Details can be seen in Gisele Dion's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gisele Dion has not made any transactions after 2021-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Gisele Dion

To

Gisele Dion Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gisele Dion owns 2 companies in total, including Cytek Biosciences Inc (CTKB) , and Inhibikase Therapeutics Inc (IKT) .

Click here to see the complete history of Gisele Dion’s form 4 insider trades.

Insider Ownership Summary of Gisele Dion

Ticker Comapny Transaction Date Type of Owner
CTKB Cytek Biosciences Inc 2021-07-22 director
IKT Inhibikase Therapeutics Inc 2022-09-01 director

Gisele Dion Latest Holdings Summary

Gisele Dion currently owns a total of 1 stock. Gisele Dion owns 5,000 shares of Cytek Biosciences Inc (CTKB) as of July 22, 2021, with a value of $32,350.

Latest Holdings of Gisele Dion

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTKB Cytek Biosciences Inc 2021-07-22 5,000 6.47 32,350

Holding Weightings of Gisele Dion


Gisele Dion Form 4 Trading Tracker

According to the SEC Form 4 filings, Gisele Dion has made a total of 1 transactions in Cytek Biosciences Inc (CTKB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cytek Biosciences Inc is the acquisition of 5,000 shares on July 22, 2021, which cost Gisele Dion around $85,000.

Insider Trading History of Gisele Dion

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gisele Dion Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gisele Dion Ownership Network

Ownership Network List of Gisele Dion

No Data

Ownership Network Relation of Gisele Dion

Insider Network Chart

Gisele Dion Owned Company Details

What does Cytek Biosciences Inc do?

Who are the key executives at Cytek Biosciences Inc?

Gisele Dion is the director of Cytek Biosciences Inc. Other key executives at Cytek Biosciences Inc include director & Chief Technology Officer Ming Yan , Chief Financial Officer Patrick Jeanmonod , and director & President and CEO Wenbin Jiang .

Cytek Biosciences Inc (CTKB) Insider Trades Summary

Over the past 18 months, Gisele Dion made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 201,900 shares made by Ming Yan , a net sale of 21,000 shares made by Patrick Jeanmonod , and a net sale of 100,000 shares made by Wenbin Jiang .

In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,900 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,900 shares.

Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytek Biosciences Inc Insider Transactions

No Available Data

Gisele Dion Mailing Address

Above is the net worth, insider trading, and ownership report for Gisele Dion. You might contact Gisele Dion via mailing address: C/o Cytek Biosciences, Inc., 46107 Landing Parkway, Fremont Ca 94538.